224 related articles for article (PubMed ID: 33847110)
1. What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications.
Serafini M; Cargnin S; Massarotti A; Tron GC; Pirali T; Genazzani AA
J Med Chem; 2021 Apr; 64(8):4410-4429. PubMed ID: 33847110
[TBL] [Abstract][Full Text] [Related]
2. Obstacles to the universal application of INNs.
Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
[TBL] [Abstract][Full Text] [Related]
3. How INNs are created. Making drug names safer by contributing to INN selection.
Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
[TBL] [Abstract][Full Text] [Related]
4. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough.
Loizides U; Dominici M; Manderson T; Rizzi M; Robertson JS; de Sousa Guimarães Koch S; Timón M; Balocco R
Cytotherapy; 2021 May; 23(5):357-366. PubMed ID: 33820700
[TBL] [Abstract][Full Text] [Related]
5. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
[No Abstract] [Full Text] [Related]
6. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022.
Rizzo C; Amata S; Pibiri I; Pace A; Buscemi S; Palumbo Piccionello A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175436
[TBL] [Abstract][Full Text] [Related]
7. Exceptions to and deviations from the INN common stem system.
Prescrire Int; 2013 May; 22(138):138-9. PubMed ID: 23819186
[TBL] [Abstract][Full Text] [Related]
8. International Nonproprietary Names (INN) for pharmaceutical substances.
Kopp-Kubel S
Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
[TBL] [Abstract][Full Text] [Related]
9. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
[TBL] [Abstract][Full Text] [Related]
10. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
[TBL] [Abstract][Full Text] [Related]
11. Think INN, prescribe INN, dispense INN: good professional practice.
Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
[TBL] [Abstract][Full Text] [Related]
12. Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
Parren PWHI; Carter PJ; Plückthun A
MAbs; 2017; 9(6):898-906. PubMed ID: 28621572
[TBL] [Abstract][Full Text] [Related]
13. Furans, thiophenes and related heterocycles in drug discovery.
Sperry JB; Wright DL
Curr Opin Drug Discov Devel; 2005 Nov; 8(6):723-40. PubMed ID: 16312148
[TBL] [Abstract][Full Text] [Related]
14. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
Ilardi EA; Vitaku E; Njardarson JT
J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
[TBL] [Abstract][Full Text] [Related]
15. The INNs and outs of antibody nonproprietary names.
Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
[TBL] [Abstract][Full Text] [Related]
16. Proposed international nonproprietary names (Prop. INN): List 55.
WHO Chron; 1986; 40(1 Suppl):1-20. PubMed ID: 3739337
[No Abstract] [Full Text] [Related]
17. INN common stem; -cept.
Prescrire Int; 2014 May; 23(149):125. PubMed ID: 24926512
[No Abstract] [Full Text] [Related]
18. International Nonproprietary Names (INN). A World Health Organization activity.
Jerome JB; Luback PM
J Am Med Womens Assoc (1972); 1972 Oct; 27(10):536-8. PubMed ID: 4342347
[No Abstract] [Full Text] [Related]
19. Synthetic cannabinoid receptor agonists: classification and nomenclature.
Potts AJ; Cano C; Thomas SHL; Hill SL
Clin Toxicol (Phila); 2020 Feb; 58(2):82-98. PubMed ID: 31524007
[No Abstract] [Full Text] [Related]
20. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
